Jonathan Blay

3.1k total citations
61 papers, 2.5k citations indexed

About

Jonathan Blay is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Jonathan Blay has authored 61 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 23 papers in Oncology and 17 papers in Immunology. Recurrent topics in Jonathan Blay's work include Adenosine and Purinergic Signaling (16 papers), Immune Cell Function and Interaction (11 papers) and Peptidase Inhibition and Analysis (6 papers). Jonathan Blay is often cited by papers focused on Adenosine and Purinergic Signaling (16 papers), Immune Cell Function and Interaction (11 papers) and Peptidase Inhibition and Analysis (6 papers). Jonathan Blay collaborates with scholars based in Canada, Slovakia and United Kingdom. Jonathan Blay's co-authors include David W. Hoskin, Kenneth D. Brown, Thomas D. White, David Conrad, Cynthia L. Richard, Jamie S. Mader, Karen Brown, Suzanne J. Furlong, Jared Butler and Michael J. Berridge and has published in prestigious journals such as The Journal of Immunology, Oncogene and Biochemical Journal.

In The Last Decade

Jonathan Blay

61 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Blay Canada 27 1.1k 750 694 631 225 61 2.5k
Silvana Morello Italy 29 718 0.6× 733 1.0× 573 0.8× 766 1.2× 199 0.9× 71 2.2k
Hoi Young Lee South Korea 33 2.5k 2.2× 227 0.3× 532 0.8× 300 0.5× 502 2.2× 81 3.5k
Nathalie Andrieu‐Abadie France 36 3.1k 2.7× 217 0.3× 724 1.0× 809 1.3× 334 1.5× 85 4.5k
Thomas McDonagh United States 18 1.1k 1.0× 342 0.5× 380 0.5× 173 0.3× 219 1.0× 28 3.1k
Khaled Méflah France 33 1.9k 1.7× 107 0.1× 580 0.8× 730 1.2× 259 1.2× 115 3.2k
Bruno Ségui France 31 1.6k 1.4× 110 0.1× 637 0.9× 726 1.2× 245 1.1× 90 2.8k
Laurence Booth United States 31 1.6k 1.4× 214 0.3× 582 0.8× 270 0.4× 194 0.9× 93 2.6k
Elena Tibaldi Italy 30 1.4k 1.2× 125 0.2× 466 0.7× 514 0.8× 243 1.1× 65 2.5k
Cynthia M. Simbulan‐Rosenthal United States 31 1.9k 1.7× 150 0.2× 1.5k 2.1× 405 0.6× 240 1.1× 69 3.0k
Chi Li United States 25 2.5k 2.2× 211 0.3× 326 0.5× 403 0.6× 429 1.9× 70 3.7k

Countries citing papers authored by Jonathan Blay

Since Specialization
Citations

This map shows the geographic impact of Jonathan Blay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Blay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Blay more than expected).

Fields of papers citing papers by Jonathan Blay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Blay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Blay. The network helps show where Jonathan Blay may publish in the future.

Co-authorship network of co-authors of Jonathan Blay

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Blay. A scholar is included among the top collaborators of Jonathan Blay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Blay. Jonathan Blay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rao, Praveen P. N., et al.. (2022). Apigenin directly interacts with and inhibits topoisomerase 1 to upregulate CD26/DPP4 on colorectal carcinoma cells. Frontiers in Pharmacology. 13. 1086894–1086894. 5 indexed citations
2.
Patel, Deep & Jonathan Blay. (2021). Seeding metastases: The role and clinical utility of circulating tumour cells. Tumor Biology. 43(1). 285–306. 2 indexed citations
3.
Wong, Shirley, et al.. (2016). Bacteriophage Applications - Historical Perspective and Future Potential. DIAL (Catholic University of Leuven). 7 indexed citations
5.
Blay, Jonathan, et al.. (2011). The dietary flavonoid apigenin enhances the activities of the anti-metastatic protein CD26 on human colon carcinoma cells. Clinical & Experimental Metastasis. 28(4). 337–349. 43 indexed citations
6.
Blay, Jonathan & Richard Bengt Price. (2010). Cellular inhibition produced by dental curing lights is a heating artifact. Journal of Biomedical Materials Research Part B Applied Biomaterials. 93B(2). 367–374. 4 indexed citations
7.
Roy, Jeremy, Elizabeth A. Cowley, Jonathan Blay, & Paul Linsdell. (2009). The intermediate conductance Ca2+‐activated K+ channel inhibitor TRAM‐34 stimulates proliferation of breast cancer cells via activation of oestrogen receptors. British Journal of Pharmacology. 159(3). 650–658. 12 indexed citations
8.
Graham, Cathy, et al.. (2007). Stereochemical Integrity of Oxazolone Ring‐Containing Jadomycins. ChemBioChem. 8(10). 1198–1203. 41 indexed citations
9.
Richard, Cynthia L., et al.. (2006). Adenosine downregulates DPPIV on HT-29 colon cancer cells by stimulating protein tyrosine phosphatase(s) and reducing ERK1/2 activity via a novel pathway. American Journal of Physiology-Cell Physiology. 291(3). C433–C444. 35 indexed citations
10.
Katuri, Varalakshmi, Yi Tang, Blair Marshall, et al.. (2005). Inactivation of ELF/TGF-β signaling in human gastrointestinal cancer. Oncogene. 24(54). 8012–8024. 35 indexed citations
12.
Mujoomdar, Michelle, et al.. (2004). Adenosine Down-Regulates the Surface Expression of Dipeptidyl Peptidase IV on HT-29 Human Colorectal Carcinoma Cells. American Journal Of Pathology. 165(1). 319–330. 35 indexed citations
14.
Butler, Jared, et al.. (2003). Adenosine inhibits activation‐induced T cell expression of CD2 and CD28 co‐stimulatory molecules: Role of interleukin‐2 and cyclic AMP signaling pathways. Journal of Cellular Biochemistry. 89(5). 975–991. 45 indexed citations
15.
Richard, Cynthia L., et al.. (2003). DIFFERENTIAL SENSITIVITY TO SHORT-CHAIN CERAMIDE ANALOGUES OF HUMAN INTESTINAL CARCINOMA CELLS GROWN IN TUMOR SPHEROIDS VERSUS MONOLAYER CULTURE. In Vitro Cellular & Developmental Biology - Animal. 39(8). 340–340. 9 indexed citations
16.
Xu, Hong‐Xi, et al.. (1999). Isolation and characterization of an anti-HSV polysaccharide from Prunella vulgaris. Antiviral Research. 44(1). 43–54. 102 indexed citations
17.
Williams, Brent A., Jonathan Blay, & David W. Hoskin. (1997). 2-Chloroadenosine Stimulates Granule Exocytosis from Mouse Natural Killer Cells: Evidence for Signal Transduction through a Novel Extracellular Receptor. Experimental Cell Research. 233(1). 187–197. 12 indexed citations
19.
Blay, Jonathan & Morley D. Hollenberg. (1989). Epidermal growth factor stimulation of prostacyclin production by cultured aortic smooth muscle cells: Requirement for increased cellular calcium levels. Journal of Cellular Physiology. 139(3). 524–530. 21 indexed citations
20.
Blay, Jonathan & Morley D. Hollenberg. (1989). Heterologous regulation of EGF receptor function in cultured aortic smooth muscle cells. European Journal of Pharmacology Molecular Pharmacology. 172(1). 1–7. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026